VON RICKENBACH JOSEF H 4
4 · Aileron Therapeutics, Inc. · Filed Aug 22, 2024
Insider Transaction Report
Form 4
VON RICKENBACH JOSEF H
Director
Transactions
- Award
Stock Option (right to buy)
2024-08-20+2,725→ 2,725 totalExercise: $2.40Exp: 2034-08-19→ Common Stock (2,725 underlying)
Footnotes (1)
- [F1]This option was granted on August 20, 2024. The shares underlying the option are scheduled to vest in full on the earlier of (i) August 20, 2025 or (ii) the date of the Issuer's 2025 Annual Meeting of Stockholders.